A Quest for Answers.
A Global Company with Expertise Across the Value Chain
Investing in Ideas
At Cannaobe our founders have built iconic companies that are fueled by bold ideas and span industries and continents.
Our Ethos
Invest in the people and ideas that will be a roadmap for the future and reshape the world around us.
As we look to the future of global health, we recognize that only by harnessing the power of innovative ideas around the world will we be able to foster the new ideas, collaborations, and strategies that are needed to achieve lasting solutions to the world’s toughest health challenges. .
Meeting Critical Covid 19
Needs Across the Globe
Cannaobe Sciences has developed the Rapid Response Network to assist state governments, healthcare facilities and corporations with a securing lifesaving personal protective equipment (PPE). The Network consists of more than 200 manufacturers located in 30 states working alongside global suppliers to to solve the immediate COVID-19 supply challenges.
For more information or press inquiries please email us here
Modern Medicine
Powered by Technology
Argos Medical Sciences is led by a passionate, driven, and knowledgeable team, including an advisory board with experience, passion, and an exciting vision for the future of medicine.
The Argos mobile App matches patients with the best possible cannabis/CBD treatment.
Powering a new era of Cannabis
& Hemp derived products
Hemp-derived CBD is a significant opportunity for Kannalíf and we are moving aggressively on the heels of the U.S. federal legalization of hemp and hemp-derived CBD products to establish ourselves as a leading vertically integrated supplier of THC-dominant, CBD-dominant and THC/CBD products to the global market.
A global Marketplace
Live your best life
NuBounty.com provides a globally accessible marketplace of loving curated CBD wellness products. The NuBounty knowledge room provides our community with latest information on CBD treatments, dosage, product reviews, and personal stories from our members.
